China NMPA UDI

China National Medicinal Product Administration (NMPA) began a UDI pilot in 2019. Like US FDA, China has specific issuing standards for UDI with some nuances in product data elements. Compliance timing has rolled out for device categories in batched numbers, with future milestones expected in 2024 and 2026 for Batch 3 Class II and Class I and remaining. Registering medical devices and subsequent UDI submissions with NMPA can be challenging. Learn highlights here in the ‘Understanding UDI Series’.